FDA recall D-0482-2017

Product

Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02

Reason for recall

Failed Dissolution Specifications

Distribution

Product was distributed to a sold customer in FL.

Key facts

Status

Terminated

Initiation date

2017-02-07

Report date

2017-03-01

Termination date

2017-05-05

Voluntary/Mandated

Voluntary: Firm initiated

Location

Indiana, PA, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0482-2017